Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 8.17 is 16% above its 5-year average of 7.06, near the high end of its 5-year range (2.77–8.94).
As of the fiscal period ended Wednesday, December 31, 2025. 39.54% above its 12-month average of 5.85.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 13 quarters.
EARNINGS PER SHARE (EPS)
8.17
EARNINGS PER SHARE (EPS) AVG TTM
5.85
EARNINGS PER SHARE (EPS) AVG 3Y
6.82
EARNINGS PER SHARE (EPS) AVG 5Y
7.06
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.54%
CURRENT VS 3Y AVG
+19.74%
CURRENT VS 5Y AVG
+15.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Solventum Corporation
Market Cap
$13.94B
Earnings Per Share (EPS)
8.17
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
Market Cap
$13.71B
Earnings Per Share (EPS)
1.18
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
11.98
Market Cap
$12.06B
Earnings Per Share (EPS)
2.10
TTM Avg
2.25
3Y Avg
2.01
5Y Avg
3.78
Market Cap
$12.05B
Earnings Per Share (EPS)
-2.10
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$12.04B
Earnings Per Share (EPS)
5.96
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$11.43B
Earnings Per Share (EPS)
4.30
TTM Avg
4.74
3Y Avg
3.13
5Y Avg
2.14
Market Cap
$16.45B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
Market Cap
$11.21B
Earnings Per Share (EPS)
0.69
TTM Avg
0.77
3Y Avg
1.27
5Y Avg
1.25
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.94B | 8.17 | 5.85 | 6.82 | 7.06 |
| The Cooper Companies, Inc. (COO)vs › | $13.71B | 1.18 | 1.92 | 1.82 | 11.98 |
| DaVita Inc. (DVA)vs › | $15.17B | 9.94 | 10.37 | 8.56 | 8.35 |
| Revvity, Inc. (RVTY)vs › | $12.06B | 2.10 | 2.25 | 2.01 | 3.78 |
| Baxter International Inc. (BAX)vs › | $12.05B | -2.10 | -1.51 | -0.65 | 0.36 |
| Align Technology, Inc. (ALGN)vs › | $12.04B | 5.96 | 5.64 | 5.43 | 9.01 |
| Insulet Corp. (PODD)vs › | $11.43B | 4.30 | 4.74 | 3.13 | 2.14 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.45B | 17.07 | 14.35 | 11.37 | 9.10 |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 0.69 | 0.77 | 1.27 | 1.25 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
Trailing EPS (TTM)
$8.17
Forward EPS (Est.)
$6.55
P/E Ratio
9.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 8.94 |
| 2024-12-31 | 2.77 |
| 2023-12-31 | 7.79 |
| 2022-12-31 | 7.79 |
| 2021-12-31 | 8.47 |
| 2020-12-31 | 6.60 |
